Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

ConclusionsOur study highlights an in-depth characterization of SCLC metabolic programming and presents glycolysis as a targetable mechanism downstream of MYC that could offer therapeutic benefit in a subset of SCLC patients.
Source: Cancer and Metabolism - Category: Cancer & Oncology Source Type: research